© 2008, Columbia Laboratories, Inc. All rights reserved.

 

Please note that the product information provided on this website is intended only for residents of the United States.

In frozen embryo transfer cycles—

 

Statistically Equal Pregnancy Rates Regardless of Serum Progesterone Level1

 

Study design: Results of a retrospective chart review in 96 women who underwent a frozen embryo transfer cycle. All patients received estradiol and, starting on cycle day 15 (2 days prior to embryo transfer), either Crinone 8% (90 mg BID), Prometrium capsules used vaginally (200 mg TID), or IM progesterone (50 mg QD).

 

*No statistically significant difference in pregnancy rate when comparing Crinone 8% and Prometrium, Crinone 8% and IM progesterone, or Prometrium and IM progesterone.

†Serum progesterone level was significantly higher with IM progesterone versus either Crinone 8% or Prometrium.

 

Prometrium is a registered trademark of Solvay Pharmaceuticals, Inc.

 

Reference: 1. Williams SC, Donahue J, Muasher SJ. Vaginal progesterone therapy during programmed cycles for frozen embryo transfer: an analysis of serum progesterone levels and pregnancy rates. Fertil Steril. 2000;74(suppl 1):S209. Abstract P-363.